| Patents for A61P 39 - General protective or antinoxious agents (19,019) |
|---|
| 01/07/2004 | EP1377300A1 Zinc ionophores as anti-stress agents |
| 01/07/2004 | EP1377164A1 Erythropoietin ameliorates chemotherapy-induced toxicity in vivo |
| 01/07/2004 | CN1466458A Use of arginine in the preparation of a medicament for the prevention and treatment of the side effcts associated with the intravenous administration |
| 01/07/2004 | CN1466451A Ion-strength independent sustained release pharmacetuical formulation |
| 01/07/2004 | CN1465403A Tetrodotoxin conjugate and medicine composition having same |
| 01/07/2004 | CN1465285A Lead-removing health care food and preparation method thereof |
| 01/06/2004 | US6673379 Use of non-alkalized cocoa solids in a drink |
| 01/06/2004 | CA2223588C Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures |
| 01/02/2004 | EP1374884A1 Proteotoxin neutralizer |
| 01/02/2004 | EP1374853A1 Cosmetic and/or dermatological composition containing at least one oxidation-sensitive hydrophilic active stabilised by at least one polymer or copolymer of maleic anhydride |
| 01/02/2004 | EP1374852A1 Cosmetic and/or dermatological Composition containing at least one oxidation-sensitive hydrophilic active stabilised by at least one polymer or copolymer of maleic anhydride |
| 01/02/2004 | EP1374851A1 Cosmetic and/or dermatological use of a composition containing at least one oxidation-sensitive hydrophilic active stabilised by at least one polymer or copolymer of maleic anhydride |
| 01/02/2004 | EP1374850A1 Cosmetic and/or dermatological composition containing at least one oxidation-sensitive hydrophilic active stabilised by at least one polymer or copolymer of maleic anhydride |
| 01/02/2004 | EP1374849A1 Cosmetic and/or dermatological use of a composition containing at least one oxidation-sensitive hydrophilic active stabilised by at least one polymer or copolymer of maleic anhydride |
| 01/02/2004 | EP1373508A2 Human cytokine receptor |
| 01/02/2004 | EP1373319A2 Composition comprising il-22 inhibitors and use thereof for treating inflammatory disorders |
| 01/02/2004 | EP1373271A1 Indole derivatives having an inhibitory effect on protein kinases |
| 01/02/2004 | EP1373263A1 Heterocyclic compounds for aging-related and diabetic vascular complications |
| 01/02/2004 | EP1373242A1 Dimeric isoflavones |
| 01/02/2004 | EP1372786A2 Cytoprotection by phosphotyrosine |
| 01/02/2004 | EP1372698A2 Use of cytokines of the tgf-beta superfamily for the treatment and diagnosis of skin related disorders |
| 01/02/2004 | EP1372695A2 Cell damage inhibitor |
| 01/02/2004 | EP1372685A1 Use of extracts of the plant litchi chinensis sonn. |
| 01/02/2004 | EP1372676A1 Pharmaceutical composition comprising copper, salicylic acid, vitamin c and zinc for use in treatment of different diseases such as bacterial or viral infection |
| 01/02/2004 | EP1372673A2 The use of non-digestible polymeric foams to sequester ingested materials, thereby inhibiting their absorption by the body |
| 01/02/2004 | EP1372654A2 Quinoline inhibitors of hyak1 and hyak3 kinases |
| 01/02/2004 | EP1372635A1 Use of creatine for the amelioration of oxidative stress |
| 01/02/2004 | EP1372627A1 Use of breakers of advanced glycation endproducts for treating deleterious effects of aging and debilitating diseases |
| 01/01/2004 | US20040002540 Method for increasing the concentration of ascorbic acid in brain tissues of a subject |
| 01/01/2004 | US20040002530 Composition for the prevention and/or treatment in newborn babies of the effects of complications during childbirth |
| 01/01/2004 | US20040001898 Fermentated dietetic fibers; anticancer agents |
| 01/01/2004 | US20040001792 Decoloring hair and skin using ascorbic acid |
| 12/31/2003 | WO2004001022A1 Probiotic propionibacterium jensenii 702 |
| 12/31/2003 | WO2004000786A1 Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same |
| 12/31/2003 | WO2004000333A1 Novel complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives |
| 12/31/2003 | WO2004000324A1 Pharmaceutical compositions for the treatment of diseases related to neurotrophines |
| 12/31/2003 | WO2003055912A3 Secreted proteins |
| 12/31/2003 | WO2002064796A3 Butyrylcholinesterase polypeptide variants with increased catalytic efficiency and methods of use |
| 12/31/2003 | WO2002060378A3 Substituted aryl compounds as cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 12/31/2003 | CN1464775A Method for processing ginseng and processed ginseng obtained by the same |
| 12/30/2003 | US6670356 Analogs of galanthamine and lycoramine as modulators of nicotinic receptors |
| 12/30/2003 | US6669966 Topically applying oxides of bismuth, cobalt, copper, iron, manganese or praseodymium, as ointments or on bandages to improve neovascularization of injuries or skin disorders |
| 12/30/2003 | CA2338325C Novel uses of ascorbyl-phosphoryl-cholesterol and compositions for practicing same |
| 12/25/2003 | US20030236280 Aminotetralin-derived urea modulators of vanilloid VR1 receptor |
| 12/25/2003 | US20030235588 Thioredoxin (TRX); administering histone deacetylase inhibitors such as trichostatin A; for treating inflammation |
| 12/24/2003 | WO2003106507A1 Per (3,6-anhydro) cyclodextrin derivatives, their preparation and use thereof for separating ions, in particular chromium and manganese anions |
| 12/24/2003 | WO2003106506A1 Low molecular weight oversulfated polysaccharide |
| 12/24/2003 | WO2003106505A1 Process for the manufacture of n-acyl-(epi)k5-amine-o-sulfate-derivatives and products thus obtained |
| 12/24/2003 | WO2003106504A1 Epimerized derivatives of k5 polysaccharide with a very high degree of sulfation |
| 12/24/2003 | WO2003106441A1 Pharmaceutical salts of reboxetine |
| 12/24/2003 | WO2003105872A1 Anti-spasmodic comprising xenon |
| 12/24/2003 | WO2003105870A1 Verotoxin production inhibitor |
| 12/24/2003 | WO2003105869A1 Inhibitor of anticancer drug side effect |
| 12/24/2003 | WO2003084940B1 Thiazolidine-4-carbonitriles and analogues and their use as dipeptidyl-peptidas inhibitors |
| 12/24/2003 | WO2003037362A3 Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism |
| 12/24/2003 | CN1462624A Medicine compsn. for antagonizing poison-side effect caused by psychotropic drug |
| 12/24/2003 | CN1462616A Method of preparing medical use injection containing high oxygen |
| 12/24/2003 | CA2489870A1 Low molecular weight oversulfated polysaccharide |
| 12/24/2003 | CA2489866A1 Process for the manufacture of n-acyl-(epi)k5-amine-o-sulfate-derivatives and products thus obtained |
| 12/24/2003 | CA2489592A1 Inhibitor of anticancer drug side effect |
| 12/23/2003 | US6667346 Method for protecting cells and tissues from ionizing radiation toxicity with α, β unsaturated aryl sulfones |
| 12/23/2003 | US6667024 Kit comprising molecule with radioisotope binding site linked to antigen-binding fragment of antibody that specifically binds to tumor associated antigen, and metal chelator and basic amino acid or peptide clearing agents |
| 12/23/2003 | CA2265983C Therapeutic use of d-methionine to reduce the toxicity of platinum-containing anti-tumor compounds |
| 12/18/2003 | WO2003104807A1 Use of corticotroph-derived glycoprotein hormone to treat inflammation and potentiate glucocorticoid action |
| 12/18/2003 | WO2003103661A1 SUBSTITUTED 3-AMINO-THIENO[2,3-b]PYRIDINE-2-CARBOXYLIC ACID AMIDE COMPOUNDS AND PROCESSES FOR PREPARING AND THEIR USES |
| 12/18/2003 | WO2003103645A1 Fractionated extraction of natural source carotenoids with a high lycopene content, using supercritical fluids |
| 12/18/2003 | WO2003103590A2 (halo-benzo carbonyl)heterobicyclic p38 kinase inhibiting agents |
| 12/18/2003 | WO2003103588A2 Methods of using artemisinin-like compounds to prevent or delay the appearance of cancer |
| 12/18/2003 | WO2003103567A2 Nitrosodiphenylamine derivatives, compositions comprising them, and the use thereof as antioxidants and spontaneous nitric oxide donors |
| 12/18/2003 | WO2002092781A3 Peptide compounds for counteracting reactive oxygen species and free radicals |
| 12/18/2003 | WO2002066668A3 Method for producing proteins by fermentation of microorganisms from the thermus family, the protein mixture thus obtained and cosmetic compositions containing same |
| 12/18/2003 | WO2002032435A9 A composition including a platelet activating factor inhibitor and an antioxidant which interferes with the arachidonic acid cascade |
| 12/18/2003 | WO2002007678A3 Mu-conopeptides |
| 12/18/2003 | US20030232865 1,4-Benzofused urea compounds useful in treating cytokine mediated diseases |
| 12/18/2003 | US20030232822 Ht3 receptor antagonists |
| 12/18/2003 | US20030232813 Novel amino substituted pyrimidinone derivatives |
| 12/18/2003 | CA2488567A1 (halo-benzo carbonyl)heterobicyclic p38 kinase inhibiting agents |
| 12/18/2003 | CA2488360A1 Covalent conjugates between artemisinin-related endoperoxides and iron-carrying proteins and methods of use |
| 12/18/2003 | CA2488347A1 Methods of using artemisinin-like compounds to prevent or delay the appearance of cancer |
| 12/18/2003 | CA2487924A1 Use of corticotroph-derived glycoprotein hormone to treat inflammation and potentiate glucocorticoid action |
| 12/17/2003 | EP1370559A1 Triazolopyridines as anti-inflammatory agents |
| 12/17/2003 | EP1370290A2 Molecular antigen array |
| 12/17/2003 | EP1370253A2 METHOD FOR PROTECTING CELLS AND TISSUES FROM IONIZING RADIATION TOXICITY WITH $g(a), $g(b) UNSATURATED ARYL SULFONES |
| 12/17/2003 | EP0424437B1 Recombinant mycobacterial expression vehicles and uses therefor |
| 12/17/2003 | CN1131226C Novel 1,2-amylic cycle disulfide, its preparation method and medicinal compositions containing same |
| 12/17/2003 | CN1131224C Luteolin and method for preparationg luteolin derivatives |
| 12/16/2003 | US6664236 Mixtures of glucosides obtained by solvent extraction from plants, comprising barlerin, acetyl barlerin, shanshizide methyl esters and adjuvants, used for detoxification, immunomodulation and as anxiolytic agents |
| 12/16/2003 | CA2119020C 3-hydroxypyridin-4-one derivatives as chelating agents |
| 12/11/2003 | WO2003101984A1 Substituted thiophenes, method for the production thereof, their use as a medicament or diagnostic reagent, and a medicament containing the same |
| 12/11/2003 | WO2003101950A2 Methods for enhancing motor performance and/or endurance |
| 12/11/2003 | WO2003101472A1 Dioxin elimination promoter |
| 12/11/2003 | WO2003101466A1 Rubrofusarin glycoside-containing composition |
| 12/11/2003 | WO2003101424A1 Modified release pharmaceutical formulation |
| 12/11/2003 | WO2003057666A3 Inhibitors of dipeptidyl peptidase iv |
| 12/11/2003 | WO2002087508A3 Nitrosated and nitrosylated nebivolol and its metabolites, compositions and methods of use |
| 12/11/2003 | WO2002067986A3 Symbiotic regenerative agent |
| 12/11/2003 | US20030229102 Sulfonamide derivatives |
| 12/11/2003 | CA2477261A1 Methods for enhancing motor performance and/or endurance |
| 12/10/2003 | EP1369124A1 High density lipoprotein against organ dysfunction following haemorrhagic shock |
| 12/10/2003 | EP1368356A2 N-but-3-enyl norbuprenorphine and its use as analgesic |